Improved Revenues Required Before Apyx Medical Corporation (NASDAQ:APYX) Stock's 28% Jump Looks Justified
Apyx Medical Reports Q3 Results and Restructuring
Apyx Medical | 10-Q: Quarterly report
Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript Summary
Apyx Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. The Stock Initially Traded Lower, but It Has Since Reversed.
Craig-Hallum Maintains Apyx Medical(APYX.US) With Buy Rating
Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates
Apyx Medical's Strategic Moves for Financial Stability
Express News | Apyx Medical: Under Agreement, Co to Receive $5 Mln Net Cash Proceeds, Issue 150,000 Shares to Perceptive
Express News | Apyx Medical: Co Shall Not Permit or Allow Operating Expenses to Exceed $40 Mln for 2025 & $45 Mln for 2026
Express News | Apyx Medical: On Nov 7 Co Entered Into Amendment No. to Credit Agreement and Guaranty
Apyx Medical Expects 2024 Revenues Of $46.6M-$47.6M Compared To Prior Guidance Of $50.6M-$52.1M Versus Consensus Of $50.767M
Express News | Apyx Medical Corp - Purchase Price of $1.18 per Share
Express News | Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
Express News | Apyx Medical Corp Outlook FY Total Rev $46.6 Mln to $47.6 Mln
Express News | Apyx Medical Corp: Right Sized Company's Board of Directors to Five Members Down From Eight
Express News | Apyx Medical Corp: Nearly 25% Reduction in U.S. Workforce
Earnings Flash (APYX) APYX MEDICAL CORPORATION Posts Q3 Revenue $11.5M
Express News | Apyx Medical Corp: Announces Cost Savings Restructuring Program
Express News | Apyx Medical Corporation Q3 Gross Margin 60.5%
No Data
No Data